Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_assertion description "[In 158 mothers with a CHD-affected child, the maternal MTHFR 677CT and TT genotypes in combination with no use of periconceptional folate supplements were associated with, respectively, a three-fold (OR 3.3 95% CI 1.46-7.32) and six-fold (OR 6.3 95% CI 2.32-17.27) increased risk for conotruncal heart defects in offspring.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_assertion evidence source_evidence_literature NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_assertion SIO_000772 16524890 NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_assertion wasDerivedFrom befree-20140225 NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_assertion wasGeneratedBy ECO_0000203 NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP730612.RAk7eLfrCeiaJ0BpLRPdLgRViR4gzn-3GBII8kq1_Bylo130_provenance.